Experimental and Theoretical Studies on Piperidine Based Heteroleptic Schiff base Ni(II) and Cu(II) Complexes Investigating DNA/Protein Binding and Anticancer Activities

Abstract

Two versatile heteroleptic Ni(II) and Cu(II) complexes, namely [Ni(L)(µ1,1-N3)(DMF)]2 (1) and [Cu(L)(2,2′-bpy)] (ClO4) (2) [HL = (E)-4-bromo-2-(((piperidine-2-ylmethyl)imono)methyl)phenol), 2,2′-bpy = 2,2′-bipyridine], have been synthesized and characterized meticulously through different experimental analyses. Single-crystal X-ray diffraction analyses reveal that the varying nuclearity of two complexes can be attributed to the different binding modes (bridging and chelating) of the coligand residues. Following their successful synthesis, both complexes are exploited to check their DNA and protein binding efficacy as a primary task towards biomedical applications, particularly in anticancer activities. Different biophysical studies confirm their strong DNA and protein binding ability. The electronic absorption spectral studies indicate remarkably high binding constant values (order ~ 105) for both complexes in their interactions with DNA and HSA. Complexes 1 and 2 show different binding modes with DNA as revealed from various experimental observations, including fluorescence displacement assays and DNA melting studies. The determined thermodynamic parameter values for complex-DNA/HSA interaction support the spontaneous interaction of the complexes towards DNA and HSA. A theoretical approach using molecular docking studies successfully explained the fact that how structural diversity of the complexes influences the interaction ability of the complexes to biomacromolecules and validates the experimental findings. In continuation, the cytotoxic effect of both complexes is assessed on HeLa (cervical cancer cell) and WI32 fibroblast (normal cell) cell lines via a dose-dependent manner. The LD50 values display higher anticancer properties of Complex 2 compared to Complex 1. Additionally, Complex 2 shows effective DNA cleavage activity. Finally, the ROS generation ability and apoptotic cell death mechanism induced by complex 2 are also confirmed by staining studies.

Supplementary files

Article information

Article type
Paper
Submitted
27 May 2025
Accepted
01 Jul 2025
First published
05 Jul 2025

New J. Chem., 2025, Accepted Manuscript

Experimental and Theoretical Studies on Piperidine Based Heteroleptic Schiff base Ni(II) and Cu(II) Complexes Investigating DNA/Protein Binding and Anticancer Activities

S. Mukherjee, B. Ari, M. Das, D. Basak, A. Bera, A. Biswas, P. Kundu, P. Brandão, S. Mondal, B. C. Samanta and T. Maity, New J. Chem., 2025, Accepted Manuscript , DOI: 10.1039/D5NJ02225H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements